- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medtronic to distribute CVD catheters
Catheter developer CardioVascular Dynamics of Irvine, CA, hassigned a co-distribution deal with cardiology device manufacturerMedtronic of Minneapolis. Medtronic will buy a minimum numberof CVD angioplasty catheters for global distribution for up tothree
Catheter developer CardioVascular Dynamics of Irvine, CA, has
signed a co-distribution deal with cardiology device manufacturer
Medtronic of Minneapolis. Medtronic will buy a minimum number
of CVD angioplasty catheters for global distribution for up to
three years. The catheters covered by the agreement use CVD's
focus technology, which concentrates the device's expansion energy
on a specific area of the balloon. CVD will continue to sell focus-technology-based
catheters through its own direct and indirect sales network.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
